(Q81340630)
Statements
The efficacy of alemtuzumab for refractory chronic lymphocytic leukemia in relation to cytogenetic abnormalities of p53 (English)
Nnenna C Osuji
Ilaria Del Giudice
Estella Matutes
Andrew C Wotherspoon
Claire Dearden
Daniel Catovsky
1 October 2005